These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36578233)

  • 1. Associations between cortical β-amyloid burden, fornix microstructure and cognitive processing of faces, places, bodies and other visual objects in early Alzheimer's disease.
    Bourbon-Teles J; Jorge L; Canário N; Martins R; Santana I; Castelo-Branco M
    Hippocampus; 2023 Feb; 33(2):112-124. PubMed ID: 36578233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between fornix microstructure and beta amyloid accelerates memory decline in clinically normal older adults.
    Rabin JS; Perea RD; Buckley RF; Johnson KA; Sperling RA; Hedden T
    Neurobiol Aging; 2019 Sep; 81():38-46. PubMed ID: 31207468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Spotorno N; Strandberg O; Vis G; Stomrud E; Nilsson M; Hansson O
    Brain; 2023 Apr; 146(4):1602-1614. PubMed ID: 36130332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural impairments in hippocampal and occipitotemporal networks specifically contribute to decline in place and face category processing but not to other visual object categories in healthy aging.
    Bourbon-Teles J; Jorge L; Canário N; Castelo-Branco M
    Brain Behav; 2021 Aug; 11(8):e02127. PubMed ID: 34184829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between PET-Assessed Amyloid Burden and Visual and Verbal Episodic Memory Performance in Elderly Subjects.
    Squarzoni P; Faria DP; Yassuda MS; Porto FHG; Coutinho AM; Costa NAD; Nitrini R; Forlenza OV; Duran FLS; Brucki SMD; Buchpiguel CA; Busatto GF
    J Alzheimers Dis; 2020; 78(1):229-244. PubMed ID: 32986673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor tractography of the fornix in cerebral amyloid angiopathy, mild cognitive impairment and Alzheimer's disease.
    Shaikh I; Beaulieu C; Gee M; McCreary CR; Beaudin AE; Valdés-Cabrera D; Smith EE; Camicioli R
    Neuroimage Clin; 2022; 34():103002. PubMed ID: 35413649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verbal memory and hippocampal volume predict subsequent fornix microstructure in those at risk for Alzheimer's disease.
    Yu J; Lee TMC;
    Brain Imaging Behav; 2020 Dec; 14(6):2311-2322. PubMed ID: 31494824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal accrual of neocortical amyloid burden is associated with microstructural changes of the fornix in cognitively normal adults.
    Song Z; Farrell ME; Chen X; Park DC
    Neurobiol Aging; 2018 Aug; 68():114-122. PubMed ID: 29602495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer's disease and normal ageing.
    Tu MC; Lo CP; Huang CF; Hsu YH; Huang WH; Deng JF; Lee YC
    PLoS One; 2017; 12(4):e0175143. PubMed ID: 28388630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer's disease.
    Kitamura S; Shimada H; Niwa F; Endo H; Shinotoh H; Takahata K; Kubota M; Takado Y; Hirano S; Kimura Y; Zhang MR; Kuwabara S; Suhara T; Higuchi M
    J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1208-1214. PubMed ID: 29884723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.
    Okada Y; Kato T; Iwata K; Kimura Y; Nakamura A; Hattori H; Toyama H; Ishii K; Ishii K; Senda M; Ito K; Iwatsubo T;
    Ann Nucl Med; 2020 Feb; 34(2):108-118. PubMed ID: 31749127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
    Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
    JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.
    Smith GS; Kuwabara H; Yan H; Nassery N; Yoon M; Kamath V; Kraut M; Gould NF; Savonenko A; Coughlin JM; Lodge M; Pomper MG; Nandi A; Holt D; Dannals RF; Leoutsakos JM
    J Alzheimers Dis; 2023; 96(1):215-227. PubMed ID: 37718818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical and Cortical Regions of Amyloid-β Pathology Measured by 11C-PiB PET Are Differentially Associated with Cognitive Functions and Stages of Disease in Memory Clinic Patients.
    Almkvist O; Brüggen K; Nordberg A
    J Alzheimers Dis; 2021; 81(4):1613-1624. PubMed ID: 33967046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.